Monthly Archives: December 2019
AGA Technical Review on Gastric Intestinal Metaplasia – Epidemiology and Risk Factors
Posted in News
Comments Off on AGA Technical Review on Gastric Intestinal Metaplasia – Epidemiology and Risk Factors
AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia
Posted in News
Comments Off on AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia
Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice
Posted in News
Comments Off on Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice
Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations
Posted in News
Comments Off on Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations
Low Rates of Genetic Counseling and Testing in Individuals at Risk for Lynch Syndrome reported in the National Health Interview Survey
Posted in News
Comments Off on Low Rates of Genetic Counseling and Testing in Individuals at Risk for Lynch Syndrome reported in the National Health Interview Survey
Promises and Potential Pitfalls of Shared Decision-making in Cancer Screening
Posted in News
Comments Off on Promises and Potential Pitfalls of Shared Decision-making in Cancer Screening
Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: a Systematic Review
Altering the intestinal microbiota has been proposed as a treatment for inflammatory bowel diseases (IBD), but there are no established associations between specific microbes and IBD. We performed a systematic review to identify frequent associations. Continue reading
Posted in News
Comments Off on Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: a Systematic Review
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients with Nonalcoholic Steatohepatitis With Cirrhosis And Portal Hypertension
Increased levels of galectin 3 have been associated with nonalcoholic steatohepatitis (NASH) and contributes to toxin-induced liver fibrosis in mice. GR-MD-02 (belapectin) is an inhibitor of galectin 3 that reduces liver fibrosis and portal hypertensio… Continue reading
Posted in News
Comments Off on Effects of Belapectin, an Inhibitor of Galectin-3, in Patients with Nonalcoholic Steatohepatitis With Cirrhosis And Portal Hypertension
Rounds: Lessons on reducing waste from a DIY handyman
The build-up of waste in health care is never ending. It’s all around us, and taming it requires perpetual action. This is where everyone can make a difference. Continue reading
Posted in News
Comments Off on Rounds: Lessons on reducing waste from a DIY handyman
Rate adjustment set for Medical Center employee parking; effective Feb. 1
Members of the Vanderbilt University Medical Center community will see an increase in monthly fees for on-campus parking, effective Feb. 1, 2020.
Upcoming changes to the fee structure for permits will impact both reserved and non-reserved parking spac… Continue reading
Posted in News
Comments Off on Rate adjustment set for Medical Center employee parking; effective Feb. 1